Literature DB >> 17578844

RIP2 mediates LPS-induced p38 and IkappaBalpha signaling including IL-12 p40 expression in human monocyte-derived dendritic cells.

Nurguel Usluoglu1, Jovan Pavlovic, Karin Moelling, Gerald Radziwill.   

Abstract

IL-12, the critical factor for the generation of the Th1 type immune response, is produced by dendritic cells (DC) upon stimulation with LPS. Different signal pathways mediate LPS-induced expression of IL-12 and involve PI3K, MAPK and the transcription factor NF-kappaB. Here, we show that the kinase Raf is involved in the expression of IL-12 in human DC stimulated by LPS. We demonstrate that Raf regulates the expression of the IL-12 subunit p40 not via the kinase MEK, the major effector of Raf in growth factor-dependent signaling, but via the receptor-interacting protein 2 (RIP2) using specific inhibitors for MAPK pathways. RIP2 is a kinase participating in LPS/Toll-like receptor 4 signaling. Knockdown of RIP2 by siRNA inhibited LPS-dependent expression of IL-12 p40. In addition, knockdown of RIP2 reduced phosphorylation of p38 MAPK, ERK and IkappaBalpha, which are known upstream regulators of IL-12 production. Thus, in human DC LPS stimulates a signal cascade that involves the Raf-dependent activation of RIP2 leading to expression of IL-12 p40.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578844     DOI: 10.1002/eji.200636388

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  RICK/RIP2 is a NOD2-independent nodal point of gut inflammation.

Authors:  Tomohiro Watanabe; Kosuke Minaga; Ken Kamata; Toshiharu Sakurai; Yoriaki Komeda; Tomoyuki Nagai; Atsushi Kitani; Masaki Tajima; Ivan J Fuss; Masatoshi Kudo; Warren Strober
Journal:  Int Immunol       Date:  2019-09-18       Impact factor: 4.823

2.  MS80, a novel sulfated polysaccharide, inhibits CD40-NF-kappaB pathway via targeting RIP2.

Authors:  Xiaoguang Du; Shan Jiang; Hongchun Liu; Xianliang Xin; Jing Li; Meiyu Geng; Handong Jiang
Journal:  Mol Cell Biochem       Date:  2010-04       Impact factor: 3.396

3.  Characterization of a profilin-like protein from Schistosoma japonicum, a potential new vaccine candidate.

Authors:  Shuang-min Zhang; Zhi-yue Lv; He-jun Zhou; Li-yan Zhang; Lin-lin Yang; Xinbing Yu; Huanqin Zheng; Zhong-dao Wu
Journal:  Parasitol Res       Date:  2008-03-06       Impact factor: 2.289

4.  Deoxypodophyllotoxin Induces a Th1 Response and Enhances the Antitumor Efficacy of a Dendritic Cell-based Vaccine.

Authors:  Jun Sik Lee; Dae Hyun Kim; Chang-Min Lee; Tae Kwun Ha; Kyung Tae Noh; Jin Wook Park; Deok Rim Heo; Kwang Hee Son; In Duk Jung; Eun Kyung Lee; Yong Kyoo Shin; Soon-Cheol Ahn; Yeong-Min Park
Journal:  Immune Netw       Date:  2011-02-28       Impact factor: 6.303

5.  Cytokine profiles of umbilical cord blood mononuclear cells upon in vitro stimulation with lipopolysaccharides of different vaginal gram-negative bacteria.

Authors:  Edith Reuschel; Martina Toelge; Kathrin Entleutner; Ludwig Deml; Birgit Seelbach-Goebel
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

6.  NOD1/RIP2 signalling enhances the microglia-driven inflammatory response and undergoes crosstalk with inflammatory cytokines to exacerbate brain damage following intracerebral haemorrhage in mice.

Authors:  Miao Wang; Xinchun Ye; Jinxia Hu; Qiuchen Zhao; Bingchen Lv; Weijing Ma; Weiwei Wang; Hanhan Yin; Qi Hao; Chao Zhou; Tao Zhang; Weifeng Wu; Yan Wang; Mingyue Zhou; Cong-Hui Zhang; Guiyun Cui
Journal:  J Neuroinflammation       Date:  2020-12-01       Impact factor: 8.322

7.  Transcriptome-Wide High-Throughput m6A Sequencing of Differential m6A Methylation Patterns in the Human Rheumatoid Arthritis Fibroblast-Like Synoviocytes Cell Line MH7A.

Authors:  Hui Jiang; Kefeng Cao; Chang Fan; Xiaoya Cui; Yanzhen Ma; Jian Liu
Journal:  J Inflamm Res       Date:  2021-02-25

Review 8.  RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases.

Authors:  Hajime Honjo; Tomohiro Watanabe; Ken Kamata; Kosuke Minaga; Masatoshi Kudo
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

9.  MiR-200c-3p inhibits LPS-induced M1 polarization of BV2 cells by targeting RIP2.

Authors:  Lei Zhao; Xiaosong Liu; Jiankai Yang; Xiaoliang Wang; Xiaomeng Liu; Jianliang Wu; Chen Li; Donggang Xu; Yuhua Hu
Journal:  Genes Genomics       Date:  2022-01-10       Impact factor: 1.839

10.  Essential Role of the Innate Immune Adaptor RIP2 in the Response to Otitis Media.

Authors:  Arwa Kurabi; Jasmine Lee; Kwang Pak; Anke Leichtle; Allen F Ryan
Journal:  Front Genet       Date:  2022-07-12       Impact factor: 4.772

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.